| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Aromatic ammonia spirit (substance) |
Is a |
True |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pipradrol |
Is a |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Deanol |
Is a |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pyrovalerone |
Is a |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fencamfamin |
Is a |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Muscle stimulant |
Is a |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| amphétamine |
Is a |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Analeptic agent |
Is a |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Stimulant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Modafinil (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amfetamine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Caffeine solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Weak central nervous system stimulants |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Weak central nervous system stimulant+vitamins |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amphetamine and cocaine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Drugs used to treat hyperactivity disorders |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Other central nervous system stimulants |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Modafinil 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Central stimulant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Caffeine 5mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amphetamine or psychostimulant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phentermine hydrochloride 30mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phentermine hydrochloride 30 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Caffeine citrate 20mg/mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely phentermine hydrochloride 18.75 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Caffeine citrate 20mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phentermine hydrochloride 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely pemoline 18.75 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pemoline 37.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely pemoline 75 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Modafinil 200mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phentermine hydrochloride 37.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely phentermine hydrochloride 37.5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin + butalbital + caffeine 325mg/50mg/40mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Caffeine + ergotamine tartrate 100mg/1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Caffeine + ergotamine tartrate 100mg/2mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acetaminophen+butalbital+caffeine 325mg/50mg/40mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acetaminophen+butalbital+caffeine 500mg/50mg/40mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phentermine hydrochloride 15mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin + caffeine + orphenadrine citrate tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Oral caffeine (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing caffeine in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing caffeine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phentermine m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing phentermine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing phendimetrazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Medicinal product acting as analeptic agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing phentermine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pemoline-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Psychostimulant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing caffeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing prolintane (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Caffeine and sodium benzoate injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing aspirin and butalbital and caffeine and codeine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing caffeine and isometheptene mucate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing aspirin and caffeine and propoxyphene hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing aspirin and caffeine and dihydrocodeine tartrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Caffeine + ergotamine tartrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Caffeine- and sodium benzoate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing butalbital and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin + caffeine + orphenadrine citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing butalbital and caffeine and codeine phosphate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing aspirin and butalbital and caffeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Doxapram hydrochloride 100mg/5mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methylphenidate hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methylphenidate hydrochloride 5mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methylphenidate hydrochloride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing methyltestosterone and pemoline and yohimbine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Doxapram hydrochloride 2mg/mL infusion solution 500mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing methylphenidate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing doxapram (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing caffeine and dihydrocodeine tartrate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Doxapram hydrochloride [respiratory use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Doxapram HCl [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methylphenidate hydrochloride 20mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely modafinil 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methylphenidate hydrochloride 18mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methylphenidate hydrochloride 36mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methylphenidate hydrochloride m/r |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dexmethylphenidate hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexmethylphenidate hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexmethylphenidate hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexmethylphenidate hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Oral methylphenidate (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]